Health Ministry’s Statement On Drug Recall

bgis Top Stories

Statement from the Ministry of Health and Wellness on Valsartan 160mg and 320mg, and Indapamide 1.5mg Recall The Ministry of Health and Wellness wishes to inform Barbadians that recent analytical results from the Medicines Quality Control and Surveillance Department (formerly CARPHA laboratory) indicated that analysis of samples of Indapamide 1.5mg and Valsartan 160mg and 320mg manufactured by Ciron Drugs and Pharmaceuticals …

FDA Valsartan Recall Not Impacting Barbados

Joy Springer Top Stories

The Ministry of Health and Wellness is assuring the public that none of the drugs identified in the December 31 recall of the hypertensive drug, Valsartan, by the United States Food and Drug Administration (FDA) is approved by the Barbados Drug Service for sale in Barbados. The FDA recall is related to the discovery of an impurity believed to increase …

Barbados Not Affected By Valsartan Recall

Joy Springer Top Stories

The Ministry of Health and Wellness has assured the public that Barbados has not been affected by the current recall of the hypertensive drug, Valsartan. The drug has been recalled due to an impurity found in a batch of products. Acting Chief Medical Officer, Dr. Kenneth George, said today that a check with the Barbados Drug Service (BDS) revealed that …